Skip to main content
Evidence Based Longevity (EBL)Check what I take
Goal: sleep

Evidence by Goal: Sleep

Every graded record measured on sleep, sleepiness, sleep apnea or the body clock, including the ones that failed. A letter here describes the human trial evidence for that use; it is not advice.

43 graded uses, grouped by what the trials measured, highest letter first within each group. Every letter is copied at build time from the record that owns it, and records graded D, tested without benefit or not yet tested, are listed with the rest.

Measured on deaths and disease events

Trials that counted deaths, heart attacks, strokes, fractures, falls, cancers or other clinical events.

  • DHard clinical endpoint · Tested, no benefit
    Device or therapy · Randomized trials and meta-analyses A study that pools the numbers from several trials into one combined estimate. of CPAP against usual care, sham A fake version of a procedure or device used as the comparison, so participants cannot tell which one they received. CPAP or inactive control
    Grade for: Heart attack, stroke and cardiovascular death in adults with moderate to severe obstructive sleep apnea, mostly without daytime sleepiness

Measured on function, or by a blinded clinician

Trials that measured performance with an instrument, or used a scale scored by a clinician who did not know the treatment.

  • AMeasured function
    Protocol · Randomized laboratory and workplace trials and meta-analyses of them (short-term alertness and performance); cohort studies An observational study that follows a group of people over time and compares what happens to them. and genetic analyses on heart disease, mortality and dementia are listed as excluded evidence and carry no letter
    Grade for: Alertness and cognitive performance in the hours after an afternoon nap, healthy adults
  • AMeasured function
    Protocol · Randomized laboratory and workplace trials and meta-analyses of them (short-term alertness and performance); cohort studies and genetic analyses on heart disease, mortality and dementia are listed as excluded evidence and carry no letter
    Grade for: Cognitive performance during a night shift after an on-shift nap
  • AMeasured function
    Protocol · Randomized laboratory and workplace trials and meta-analyses of them (short-term alertness and performance); cohort studies and genetic analyses on heart disease, mortality and dementia are listed as excluded evidence and carry no letter
    Grade for: Memory retention after an afternoon nap
  • AMeasured function
    Device or therapy · Randomized trials and meta-analyses of CPAP against usual care, sham CPAP or inactive control
    Grade for: Daytime sleepiness measured by the maintenance of wakefulness test, in moderate to severe sleep apnea with daytime sleepiness
  • BMeasured function
    Supplement · Meta-analyses of randomized trials, with per-use rows
    Grade for: Sleep onset timing in delayed sleep phase disorder
  • CMeasured function
    Supplement · Meta-analyses of randomized trials, with per-use rows
    Grade for: Sleep onset latency and sleep quality (primary sleep disorders)
  • CMeasured function
    Supplement · Meta-analyses of randomized trials, with per-use rows
    Grade for: Sleep in adults with high blood pressure taking beta-blockers
  • CMeasured function
    Supplement · Small randomized trials; two meta-analyses for exercise recovery
    Grade for: Sleep quality and duration
  • CMeasured function
    Protocol · Meta-analysis of randomized trials
    Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score.: Sleep onset and sleep efficiency at low doses (0.3 to 0.5 mg)
  • CMeasured function
    Protocol · Randomized laboratory and workplace trials and meta-analyses of them (short-term alertness and performance); cohort studies and genetic analyses on heart disease, mortality and dementia are listed as excluded evidence and carry no letter
    Grade for: A short nap combined with caffeine for afternoon sleepiness
  • CMeasured function
    Protocol · Randomized laboratory and workplace trials and meta-analyses of them (short-term alertness and performance); cohort studies and genetic analyses on heart disease, mortality and dementia are listed as excluded evidence and carry no letter
    Grade for: Reducing habitual napping in older adults: verbal memory over one year
  • CMeasured function
    Protocol · A meta-analysis of small experimental studies, and a null crossover A trial design in which each participant receives both the treatment and the comparison, one after the other, and serves as their own control. trial
    Endpoint: Sleep onset latency and sleep quality after a warm bath or shower one to two hours before bed
  • CMeasured function
    Protocol · Randomized laboratory and clinical trials and meta-analyses of them; population studies of personal light exposure, mood, sleep and mortality are listed as excluded evidence and carry no letter
    Grade for: Insomnia: sleep measured by actigraphy, polysomnography and questionnaires
  • CMeasured function
    Protocol · Randomized laboratory and clinical trials and meta-analyses of them; population studies of personal light exposure, mood, sleep and mortality are listed as excluded evidence and carry no letter
    Grade for: Delayed sleep phase and late sleepers: sleep timing and daytime function
  • CMeasured function
    Protocol · Randomized laboratory and clinical trials and meta-analyses of them; population studies of personal light exposure, mood, sleep and mortality are listed as excluded evidence and carry no letter
    Grade for: Dementia in care facilities: nighttime sleep with morning bright light
  • CMeasured function
    Protocol · Randomized laboratory and clinical trials and meta-analyses of them; population studies of personal light exposure, mood, sleep and mortality are listed as excluded evidence and carry no letter
    Grade for: Older adults without dementia: sleep with brighter morning or daytime indoor light
  • CMeasured function
    Protocol · Randomized laboratory and clinical trials and meta-analyses of them; population studies of personal light exposure, mood, sleep and mortality are listed as excluded evidence and carry no letter
    Grade for: Rotating-shift nurses: daytime sleepiness and reaction time with brief morning light
  • CMeasured function
    Device or therapy · Randomized controlled trials People are assigned to the treatment or a comparison by chance, so the groups differ only in what they received. It is the design that can show cause and effect., one small trial per indication; the one hard-endpoint trial null
    Grade for: Sleep time and efficiency in people with sleep disorders
  • DMeasured function · Not yet tested
    Protocol · Randomized laboratory and clinical trials and meta-analyses of them; population studies of personal light exposure, mood, sleep and mortality are listed as excluded evidence and carry no letter
    Grade for: Healthy adults: outdoor light within a fixed window after waking, for sleep, mood or energy

Measured on a blood marker or other stand-in

Trials that measured a number standing in for the outcome, such as blood pressure, LDL Low-density lipoprotein cholesterol, the cholesterol fraction most closely tied to plaque in the arteries. cholesterol or HbA1c A blood test that reflects average blood sugar over the previous two to three months.. These letters stop at B.

  • BSurrogate biomarker
    Protocol · Randomized laboratory and clinical trials and meta-analyses of them; population studies of personal light exposure, mood, sleep and mortality are listed as excluded evidence and carry no letter
    Grade for: Body clock timing (melatonin onset) moved earlier, healthy adults
  • BSurrogate biomarker
    Device or therapy · Randomized trials and meta-analyses of CPAP against usual care, sham CPAP or inactive control
    Grade for: Blood pressure in adults with obstructive sleep apnea
  • BSurrogate biomarker
    Device or therapy · A randomized crossover against CPAP and network meta-analyses of randomized trials
    Grade for: Apnea severity, daytime sleepiness and blood pressure against inactive control and against CPAP
  • BSurrogate biomarker
    Device or therapy · Randomized sham-controlled, delayed-activation and withdrawal trials of implanted stimulators
    Grade for: Apnea-hypopnea index and Epworth sleepiness in implanted adults with moderate to severe sleep apnea who cannot use CPAP
  • BSurrogate biomarker
    Prescription · Randomized controlled trials
    Grade for: Apnea-hypopnea index in adults with obesity and moderate to severe obstructive sleep apnea
  • BSurrogate biomarker
    Prescription · Randomized controlled trials (phase 2 and phase 3)
    Grade for: Apnea-hypopnea index in adults with obesity and moderate to severe obstructive sleep apnea
  • CSurrogate biomarker
    Supplement · RCTs Randomized controlled trial: people are assigned to the treatment or a comparison by chance, so the groups differ only in what they received. It is the design that can show cause and effect. (small) + systematic review A review that searches for every study on a question using a method set in advance, then assesses them together.
    Endpoint: Sleep quality, mood and heart-rate variability (self-report and surrogate)
  • CSurrogate biomarker
    Device or therapy · Randomized trials of sleep extension and a meta-analysis of them; mortality data are observational Research that watches what people already do rather than assigning a treatment. It can show that two things travel together, not that one causes the other. and carry no grade
    Grade for: Blood pressure, insulin sensitivity and glucose after behavioral sleep extension in habitual short sleepers
  • CSurrogate biomarker
    Device or therapy · Randomized trials of sleep extension and a meta-analysis of them; mortality data are observational and carry no grade
    Grade for: Energy intake and body weight after sleep extension in adults with overweight who sleep under 6.5 hours
  • CSurrogate biomarker
    Device or therapy · Randomized sham-controlled, delayed-activation and withdrawal trials of implanted stimulators
    Grade for: Blood pressure in implanted adults with obstructive sleep apnea
  • CSurrogate biomarker
    Device or therapy · One sham-controlled randomized trial of a vibration device; pooled analyses mix cohort studies
    Grade for: Apnea-hypopnea index and daytime sleepiness in position-dependent obstructive sleep apnea
  • CSurrogate biomarker
    Device or therapy · Two sham-controlled randomized trials with opposite results, and a null crossover after stroke
    Grade for: Apnea-hypopnea index and Epworth sleepiness in obstructive sleep apnea
  • DSurrogate biomarker · Tested, no benefit
    Device or therapy · RCT + meta-analysis of randomized trials
    Grade for: Sleep apnea severity (apnea-hypopnea index)

Measured on what people reported

Trials that asked people how they felt or slept. These letters stop at B.

Related pages

Build e404c85, November 2026